SEC-sourced researchBeta
OCUL
OCULAR THERAPEUTIX, INC
Company comparison ↗
Data passport
- CIK
- 0001393434
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Oct 2, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 58,443,000.0000 | Feb 5, 2026 |
| December 2024 | 63,723,000.0000 | Feb 5, 2026 |
| December 2025 | 51,951,000.0000 | Feb 5, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 51,951,000.0000 | -265,939,000.0000 | -204,883,000.0000 | 808,057,000.0000 | 153,747,000.0000 | Feb 5, 2026 |
| December 2024 | 63,723,000.0000 | -193,506,000.0000 | -134,677,000.0000 | 457,935,000.0000 | 142,591,000.0000 | Feb 5, 2026 |
| December 2023 | 58,443,000.0000 | -80,736,000.0000 | -70,234,000.0000 | — | — | Feb 5, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $51.95M | December 2025 | Feb 5, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $63.72M | December 2024 | Feb 5, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$265.94M | December 2025 | Feb 5, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$204.88M | December 2025 | Feb 5, 2026 | 10-K |
| Total assetsAssets | $808.06M | December 2025 | Feb 5, 2026 | 10-K |
| Total liabilitiesLiabilities | $153.75M | December 2025 | Feb 5, 2026 | 10-K |